You are here: Home - Investing - Experienced Investor - News -

Stock of the week: Hikma Pharmaceuticals

0
Written by: YourMoney.com
28/08/2018
Graham Spooner, investment research analyst at The Share Centre, explains why he’s picked Hikma as stock of the week.

This week’s stock of the week is international pharmaceutical company Hikma Pharmaceuticals which has recently impressed the market with raised forecasts for 2018.

Hikma is set apart from its larger pharmaceutical rivals in that its focus on both branded and unbranded generic drugs and its sales exposure is geared towards the Middle Eastern, North African and American markets.

The group was founded in Jordan in the late seventies and subsequently grew due to demand for affordable drugs and the needs of a growing population in the region. The trend that generic drugs will continue to take an increasing share of the market is becoming more apparent and Hikma is in a good position to benefit from this.

In regards to products, the group holds a strong pipeline which are currently seeking FDA approval and despite the setback in the launch of a generic version of Glaxo’s Advair Diskus (asthma) product, management remain confident of addressing the US regulators demands, with new data expected in 2019.

Interim results in August gave the share price a boost with earnings at the top end of expectations. Profit rose by 41% to $141m on the back of an 11% rise in revenue to $989m. The dividend was 12 cents (11c). The important injectables business performed well in the US. The company raised its guidance for the year for its generics and injectables divisions.

The company hope to be well positioned from the many drivers of growth in this sector and to take full advantage it continues to place emphasis on its pipeline. Improved results this year has seen a sharp rebound in the share price to a 15-month high, following on from a difficult 2017.

However, we continue with our ‘buy’ recommendation for investors seeking capital growth and willing to accept a higher level of risk.

There are 0 Comment(s)

If you wish to comment without signing in, click your cursor in the top box and tick the 'Sign in as a guest' box at the bottom.

Are you a first-time buyer looking for a mortgage?

Look no further, get the help you need by searching for your perfect mortgage

Five ways to get on the property ladder without the Bank of Mum and Dad

A report suggests the Bank of Mum and Dad is running low on funds. Fortunately, there are other options for st...

The essential Your Money guide to the April 2018 tax changes

As we head into the 2018/19 tax year, a number of key changes take place to existing policies while some new i...

A guide to switching energy provider

All you need to know about switching from one energy supplier to another.

What will happen if rates change

How your finances will be impacted by a rise in interest rates.

Regular Savings Calculator

Small regular contributions can build up nicely over time.

Online Savings Calculator

Work out how your online savings can build over time.

Having a baby and your finances: seven top tips

We’re guessing the Duchess of Cambridge won’t be fretting about maternity pay or whether she’ll still be...

Protecting family wealth: 10 tips for cutting inheritance tax

Inheritance tax - sometimes known as 'death tax' - can cause even more heartache for bereaved families. But th...

Travel insurance: Five tips to ensure a successful claim

Ahead of your summer holiday, it’s important to make sure you have the right level of travel cover or you co...

YourMoney.com Awards 2018

Now in their 21st year, our awards recognise the companies offering the best products and services to consumers

Money Tips of the Week

Read previous post:
Loyal customers hit with ‘excessive’ insurance premiums

Loyal insurance customers are being penalised with “excessive” price hikes for staying with their provider, an investigation reveals.

Close